Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Researchers at Zyngenia disclose novel fusion proteins

Sep. 6, 2012

Novel monoclonal antibodies patented by IRM and Novartis

Sep. 6, 2012

Affectis Pharmaceuticals presents novel P2X7 receptor antagonists

Sep. 6, 2012

New tamsulosin prodrugs prepared by Synthon

Sep. 6, 2012

Novel antibacterial agents presented by Daiichi Sankyo

Sep. 5, 2012

Indiana University researchers divulge new peptide phospholipid conjugates

Sep. 5, 2012

Plexxikon discloses novel protein kinase inhibitors

Sep. 5, 2012

Russian group prepares new monoclonal antibodies

Sep. 5, 2012

Roche Glycart patents novel IL-2 immunoconjugates

Sep. 5, 2012

Bristol-Myers Squibb patents new agents for HIV

Sep. 4, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...